Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Hypocretin levels in sporadic and familial cases of canine narcolepsy.

Ripley B, Fujiki N, Okura M, Mignot E, Nishino S.

Neurobiol Dis. 2001 Jun;8(3):525-34.

PMID:
11442359
2.

Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.

Dalal MA, Schuld A, Haack M, Uhr M, Geisler P, Eisensehr I, Noachtar S, Pollm├Ącher T.

Neurology. 2001 Jun 26;56(12):1749-51. Erratum in: Neurology 2002 Jan 22;58(2):334.

PMID:
11425946
3.

Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.

Hungs M, Fan J, Lin L, Lin X, Maki RA, Mignot E.

Genome Res. 2001 Apr;11(4):531-9.

4.

Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, Okun M, Rogers W, Brooks S, Mignot E.

Ann Neurol. 2001 Sep;50(3):381-8.

PMID:
11558795
5.

Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.

Tsukamoto H, Ishikawa T, Fujii Y, Fukumizu M, Sugai K, Kanbayashi T.

Neuropediatrics. 2002 Feb;33(1):51-2.

PMID:
11930279
6.

CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.

Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, Tsukamoto H, Fujii Y, Nishino S, Shimizu T.

J Sleep Res. 2002 Mar;11(1):91-3.

7.

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

Ripley B, Overeem S, Fujiki N, Nevsimalova S, Uchino M, Yesavage J, Di Monte D, Dohi K, Melberg A, Lammers GJ, Nishida Y, Roelandse FW, Hungs M, Mignot E, Nishino S.

Neurology. 2001 Dec 26;57(12):2253-8.

PMID:
11756606
8.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S.

Arch Neurol. 2002 Oct;59(10):1553-62.

PMID:
12374492
9.

CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.

Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, Maly F, Besset A, Touchon J, Billiard M, Tafti M, Bassetti CL.

J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1667-73.

10.

Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons.

Kanbayashi T, Yano T, Ishiguro H, Kawanishi K, Chiba S, Aizawa R, Sawaishi Y, Hirota K, Nishino S, Shimizu T.

Sleep. 2002 May 1;25(3):337-9.

PMID:
12003164
11.

Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy.

Mishima K, Fujiki N, Yoshida Y, Sakurai T, Honda M, Mignot E, Nishino S.

Sleep. 2008 Aug;31(8):1119-26.

12.

Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.

Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH.

Sleep. 2002 Nov 1;25(7):733-6.

PMID:
12405608
13.

The hypocretin/orexin system in health and disease.

Nishino S.

Biol Psychiatry. 2003 Jul 15;54(2):87-95. Review. Erratum in: Biol Psychiatry. 2003 Jul 15;54(2):175.

PMID:
12873797
14.

Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers.

John J, Wu MF, Maidment NT, Lam HA, Boehmer LN, Patton M, Siegel JM.

J Physiol. 2004 Oct 15;560(Pt 2):587-92. Epub 2004 Aug 12.

15.

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).

Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.

Sleep Med. 2003 Jan;4(1):7-12.

PMID:
14592354
16.
17.

Narcolepsy and the hypocretins.

Wurtman RJ.

Metabolism. 2006 Oct;55(10 Suppl 2):S36-9. Review.

PMID:
16979425
18.

Hypocretin deficiency in familial symptomatic narcolepsy.

Melberg A, Ripley B, Lin L, Hetta J, Mignot E, Nishino S.

Ann Neurol. 2001 Jan;49(1):136-7. No abstract available.

PMID:
11198287
19.

Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.

Nishino S, Fujiki N, Ripley B, Sakurai E, Kato M, Watanabe T, Mignot E, Yanai K.

Neurosci Lett. 2001 Nov 9;313(3):125-8.

PMID:
11682143
20.

On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy.

Mignot E, Chen W, Black J.

Sleep. 2003 Sep;26(6):646-9. No abstract available. Erratum in: Sleep. 2003 Nov 1;26(7):784.

PMID:
14572113
Items per page

Supplemental Content

Write to the Help Desk